- Home
- ATOS vs TYGO Comparison
ATOS vs TYGO Comparison
Compare ATOS & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- TYGO
- Stock Information
- Founded
- ATOS 2009
- TYGO 2007
- Country
- ATOS United States
- TYGO United States
- Employees
- ATOS N/A
- TYGO N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- TYGO Semiconductors
- Sector
- ATOS Health Care
- TYGO Technology
- Exchange
- ATOS Nasdaq
- TYGO Nasdaq
- Market Cap
- ATOS 107.2M
- TYGO 86.2M
- IPO Year
- ATOS 2012
- TYGO N/A
- Fundamental
- Price
- ATOS $0.94
- TYGO $1.31
- Analyst Decision
- ATOS Strong Buy
- TYGO Strong Buy
- Analyst Count
- ATOS 3
- TYGO 2
- Target Price
- ATOS $6.17
- TYGO $3.75
- AVG Volume (30 Days)
- ATOS 1.5M
- TYGO 53.8K
- Earning Date
- ATOS 08-11-2025
- TYGO 08-05-2025
- Dividend Yield
- ATOS N/A
- TYGO N/A
- EPS Growth
- ATOS N/A
- TYGO N/A
- EPS
- ATOS N/A
- TYGO N/A
- Revenue
- ATOS N/A
- TYGO $63,051,000.00
- Revenue This Year
- ATOS N/A
- TYGO $69.44
- Revenue Next Year
- ATOS N/A
- TYGO $21.75
- P/E Ratio
- ATOS N/A
- TYGO N/A
- Revenue Growth
- ATOS N/A
- TYGO N/A
- 52 Week Low
- ATOS $0.55
- TYGO $0.58
- 52 Week High
- ATOS $1.66
- TYGO $1.80
- Technical
- Relative Strength Index (RSI)
- ATOS 58.44
- TYGO 56.14
- Support Level
- ATOS $0.81
- TYGO $1.21
- Resistance Level
- ATOS $0.88
- TYGO $1.36
- Average True Range (ATR)
- ATOS 0.05
- TYGO 0.11
- MACD
- ATOS 0.01
- TYGO -0.01
- Stochastic Oscillator
- ATOS 84.07
- TYGO 40.48
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.